)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Seelos Therapeutics
Seelos Therapeutics (SEEL.Q) investor relations material
Seelos Therapeutics has been otc
Seelos Therapeutics Proxy Filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy Filing summary24 Oct, 2024
Executive summary
Annual Meeting of Stockholders postponed to November 25, 2024, due to anticipated lack of quorum and to allow more time for proxy solicitation.
Record date for voting remains August 19, 2024; prior votes remain valid unless changed by stockholders.
Company focuses on developing therapies for central nervous system disorders and rare diseases.
Forward-looking statements highlight risks including stockholder approval, capital raising, and stock price volatility.
Voting matters and shareholder proposals
Board unanimously recommends voting FOR all director nominees and proposals listed in the proxy statement.
Stockholders are urged to vote promptly to ensure their shares are counted at the postponed meeting.
Board of directors and corporate governance
Directors, executive officers, and management are actively participating in proxy solicitation.
Information on directors' and officers' security holdings is available in the definitive proxy statement and SEC filings.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Seelos Therapeutics
- Registering shares for resale from warrant exercises as financial and Nasdaq risks persist.SEEL.Q
Registration Filing - Annual meeting to vote on director elections, auditor, executive pay, and major share issuances.SEEL.QProxy Filing
- Shareholders will vote on director elections, auditor ratification, and major stock issuance approvals.SEEL.QProxy Filing
- Annual Meeting postponed to October 25, 2024; board urges support for all proposals.SEEL.QProxy Filing
- Biopharma seeks funding via stock and warrants to advance CNS assets and address urgent financial risks.SEEL.QRegistration Filing
- Biopharma advancing CNS assets faces financial strain, debt risk, and Nasdaq delisting challenges.SEEL.QRegistration Filing
- Q2 2024 net income positive, but liquidity concerns and Nasdaq compliance risks persist.SEEL.QQ2 2024
Seelos Therapeutics
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Seelos Therapeutics, Inc. is a biotechnology company focused on developing treatments for central nervous system disorders and other rare diseases. The company’s research and development efforts target neurological, psychiatric, and neurodegenerative conditions. The company is headquartered in New York, New York, and its shares are listed on the OTCQB.